CIK 0001655759 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 262.6 M | 131.4 M | ||
| Net income (USD) | -119.3 M | -70.3 M | ||
| Diluted EPS (USD/shares) | -1.14 | -5.31 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-28 | S-8 | S-8 | |
| 2026-09-22 | 144 | 144 | |
| 2026-09-09 | 144 | 144 | |
| 2026-09-04 | 144 | 144 | |
| 2026-08-31 | S-8 | S-8 | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-04 | 144 | 144 | |
| 2026-08-04 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | 8-K | 8-K items 2.02,9.01 | 2026-08-04 |
| 2026-07-09 | 144 | 144 | |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-26 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-25 | 8-K | 8-K items 5.07 | 2026-06-24 |
| 2026-06-24 | 4 | FORM 4 | 2026-06-24 |
| 2026-06-23 | 144 | 144 | |
| 2026-06-22 | 8-K | 8-K items 5.02 | 2026-06-22 |
| 2026-06-18 | 4 | FORM 4 | 2026-06-17 |
| 2026-06-17 | 144 | 144 | |
| 2026-06-16 | 8-K | 8-K items 8.01 | 2026-06-11 |
| 2026-06-02 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-06-02 |
| 2026-05-22 | 4 | FORM 4 | 2026-05-21 |
Forms on file (last 1,000): 4 243, 8-K 114, 3 36, SC 13G/A 30, 144 29, 10-Q 24, SC 13G 17, S-8 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ARVN (0.002 USD), /gw/filings/filings?ticker=ARVN&form=8-K, /gw/filings/facts?ticker=ARVN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange